MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies _ Alzheimers & Dementia
NKGen Biotech, Inc. (NASDAQ: NKGN)*
Organization & Developments: NKGen Biotech
Parents
NKGen Biotech, Inc. (NASDAQ: NKGN)*
Children
*
*Candidates based on proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells
*Developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells.
*NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells.
2025: Received FDA Fast Track designation for troculeucel, its ex vivo expanded autologous NK cell therapy for moderate Alzheimer’s disease.
Jumps
Finance & Acquisition: NKGen Biotech
Key People: NKGen Biotech